Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release announcing the detailed voting results of the Combined General Meeting held on June 4, 2026. It lists resolutions adopted or rejected, vote percentages, and changes to board appointments and financial approvals. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA), which covers official results from shareholder votes at general meetings.
2026-06-04 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release reporting the voting outcomes of resolutions at Mauna Kea Technologies’ Combined General Meeting held on June 4, 2026. It lists resolutions adopted, vote percentages, and items not approved, matching the definition of Declaration of Voting Results & Voting Rights Announcements. It is not the AGM presentation itself, nor a management report or financial report, but specifically the voting results announcement.
2026-06-04 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a monthly press release providing the total number of shares and voting rights as required under French law (Article L233-8-II and AMF regulations). It is not a full financial report or management discussion, but an official announcement of voting rights metrics. This matches the “Declaration of Voting Results & Voting Rights Announcements” category, which covers voting rights disclosures. Therefore, the correct classification is DVA.
2026-06-03 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Regulatory Filings Classification · 85% confidence The document is a press release (“COMMUNIQUÉ DE PRESSE”) under French AMF rules (Art. 223-16 RG AMF) providing the total number of shares and voting rights as of a given date. It is a routine regulatory compliance announcement rather than an actual financial report, proxy, dividend notice, or capital increase. It does not announce a new share issue, board change, dividend, or AGM voting result, so it falls under the general regulatory announcement fallback category.
2026-06-03 French
Inside Information / Other news releases
Regulatory Filings Classification · 30% confidence The document is a corporate press release announcing a new scientific publication in an academic journal about a medical device’s clinical study results. It does not contain financial statements, investor slide deck content, voting results, regulatory certifications, or details of share transactions. It is not announcing a company financial report nor is it a management or earnings call transcript. Thus it does not fit any specialized filing category and falls into the fallback ‘Regulatory Filings’ (RNS) bucket for miscellaneous corporate announcements.
2026-06-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the publication of a scientific study in an external medical journal. It contains no financial results, no regulatory filings, no voting or management changes, and is not an investor presentation or annual/interim report. It does not fit any specialized category, so it falls into the fallback “Regulatory Filings” category for miscellaneous announcements (RNS).
2026-06-03 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.